Last $70.39 USD
Change Today -2.27 / -3.12%
Volume 143.3K
USNA On Other Exchanges
New York
As of 8:04 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

usana health sciences inc (USNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/22/13 - $92.00
52 Week Low
01/16/14 - $55.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

usana health sciences inc (USNA) Related Bloomberg News

View More Bloomberg News

usana health sciences inc (USNA) Related Businessweek News

No Related Businessweek News Found

usana health sciences inc (USNA) Details

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products focusing on chronic degenerative disease worldwide. It offers the USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The company also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products designed specifically for prenatal, infant, and young child age groups in China. In addition, it offers materials and online tools, such as associate starter kit and product brochures that are designed to assist associates in building their businesses and in marketing products. USANA Health Sciences, Inc. primarily distributes its products through a network marketing system of independent distributors. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

1,480 Employees
Last Reported Date: 03/13/14
Founded in 1992

usana health sciences inc (USNA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $530.8K
Founder and Chairman
Total Annual Compensation: --
Chief Financial Officer and Principal Account...
Total Annual Compensation: $317.7K
President of the Americas, Europe & South Pac...
Total Annual Compensation: $583.5K
President of Asia & Greater China Operations
Total Annual Compensation: $575.1K
Compensation as of Fiscal Year 2013.

usana health sciences inc (USNA) Key Developments

USANA Health Sciences Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 29, 2014; Revises Earnings Guidance for the Year 2014

USANA Health Sciences Inc. reported unaudited consolidated earnings results for the first quarter ended March 29, 2014. For the quarter, the company reported net sales of $182,401,000 against $169,082,000 a year ago. Earnings from operations were $25,122,000 against $26,562,000 a year ago. Earnings before income taxes were $25,247,000 against $26,536,000 a year ago. Net earnings were $16,537,000 or $1.28 per diluted share against $17,779,000 or $1.15 per diluted share a year ago. The increase in Net Sales were driven by overall customer growth of more than 16.0%, which was largely due to the initiatives implemented by the company in 2013. Net sales growth, however, was negatively impacted by unfavorable changes in currency exchange rates, which reduced net sales for the quarter by $5.0 million, as approximately 80% of the company's sales are outside of the U.S. The challenging media and regulatory environment that emerged in China during the quarter also negatively impacted net sales. The decrease in net earnings resulted primarily from higher Associate Incentives expense due to the pricing and compensation plan initiatives implemented in 2013. The decrease in earnings per share was attributed to lower net earnings and a higher number of diluted shares outstanding. The company revised earnings guidance for the year 2014. Consolidated net sales expected to be in between $770 million and $790 million compared to its previous guidance of $790 million to $810 million and earnings per share to be in between $5.50 and $5.65 compared to its previous guidance of $5.80 and $5.95. The company is expecting its total CapEx, which includes its new facility and branch upgrades in China, to be a little north of $40 million for the full year 2014. For the full year of 2014, the company estimates earnings from operations in the range of 14.5% to 15% of net sales.

USANA Health Sciences Inc. to Report Q1, 2014 Results on Apr 29, 2014

USANA Health Sciences Inc. announced that they will report Q1, 2014 results at 5:00 PM, Eastern Standard Time on Apr 29, 2014

USANA Health Sciences Inc., Q1 2014 Earnings Call, Apr 30, 2014

USANA Health Sciences Inc., Q1 2014 Earnings Call, Apr 30, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
USNA:US $70.39 USD -2.27

USNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Inter Parfums Inc $27.67 USD +0.33
Shaklee Global Group Inc ¥4,940 JPY -30.00
Vitamin Shoppe Inc $44.11 USD -0.02
WD-40 Co $69.91 USD +0.36
View Industry Companies

Industry Analysis


Industry Average

Valuation USNA Industry Range
Price/Earnings 13.4x
Price/Sales 1.4x
Price/Book 3.6x
Price/Cash Flow 13.0x
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact USANA HEALTH SCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at